Drugs / recombinant FSH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04446845 | Oct 2020 → Jan 2023 | infertility disorder | Fundacion Dexeus | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recombinant FSH | “recombinant FSH (or other products based on FSH) are given at the beginning of the follicular phase” NCT04446845 ↗ |
| Known as | r-FSH | “r-FSH of 250 IU per day will start” NCT04446845 ↗ |